Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Advances in the pathogenic, genetic and immunological studies of leprosy

Mi Z, Liu H, Zhang F. Elsevier BV. hLife. 2023;
Download PDF
Publication

Field-friendly anti-PGL-I serosurvey in children to monitor transmission in Bihar, India.

Pierneef L, Malaviya P, van Hooij A, et al. Frontiers in medicine. 2023;
Download PDF
Publication

Implementation of suitable optimal control strategy through introspection of different delay induced mathematical models for leprosy: A comparative study

Ghosh S, Roy AK, Roy PK. Wiley. Optimal Control Applications and Methods. 2023;
Publication

43790 Epidemiological Analysis Of Leprosy In Brazil In The Past 10 Years

Dultra M, Florence T, Gallotti S, et al. Elsevier BV. Journal of the American Academy of Dermatology. 2023; 89 (3) : AB161.
Publication

Early lesions and the development and incidence of leprosy in the children of lepers

Gomez L., Basa J. A, Nicolas C. Philippine Journal of Science. 1922; 21 (3) : 233-256.
Download PDF
Publication

Comportamiento clínico-epidemiológico de la Lepra en Granma durante el período enero-diciembre de 2022

Bring L. R. G, García R. G, Orosco D. M, et al. Universidad de Granma. Revista Granmense de Desarrolo Local. 2023; 7 (4) : 83-94.
Download PDF
Publication

Weekly epidemiological record - Global leprosy (Hansen disease) update, 2022: new paradigm – control to elimination

World Health Organization . Weekly epidemiological record. 2023; 37 (98) : 409–430.
Download PDF
Publication

Leprosy Classification, Clinical Features, Epidemiology, and Host Immunological Responses: Failure of Eradication in 2023

Alrehaili J. Springer Science and Business Media LLC. Cureus. 2023;
Download PDF
Publication

[The plans of Ernesto Ottoni to Combat the "affliction of lepers:" lazarettos, treatments, and endeavors to tackle leprosy in nineteenth century São Paulo].

Abreu J, Quadros L. Historia, ciencias, saude--Manguinhos. 2023;
Download PDF
Publication

Hansen’s Disease and One Health

Collin SM, Pettan-Brewer C, Rabinowitz PR, et al. Springer International Publishing. Hansen’s Disease. 2023;

Pagination

  • Previous page ‹‹
  • Page 11
  • Next page ››
Subscribe to Transmission

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD